Characterization of methicillin-resistant <i>Staphylococcus aureus</i> in Canadian hospitals: 17 years of the CANWARD study (2007–23)
The changing epidemiology of MRSA in Canadian hospitals warrants continued national surveillance efforts as a resource to support therapeutic guidelines and infection control and prevention programmes.
Authors
- George R. Golding (ORCID: https://orcid.org/0000-0002-4285-4747)
- Melissa McCracken (ORCID: https://orcid.org/0000-0003-2520-327X)
- Heather J. Adam (ORCID: https://orcid.org/0000-0002-5646-6454)
- Melanie R. Baxter
- Philippe Lagacé‐Wiens (ORCID: https://orcid.org/0000-0002-5826-2869)
- Kimberly A. Nichol (ORCID: https://orcid.org/0000-0002-1467-4917)
- George G. Zhanel (ORCID: https://orcid.org/0000-0002-3238-0082)
- James A. Karlowsky (ORCID: https://orcid.org/0009-0004-3330-0285)
- Anissa Brahami
Institutions
- Manitoba Health (CA)
- Public Health Agency of Canada (CA)
- Health Sciences Centre (CA)
- Shared Health (CA)
- University of Manitoba (CA)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1093/jac/dkaf218
- Citations
- 2
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 2.79
Funders
- Pfizer
- University of Manitoba
- Merck Canada
- Sandoz Canada